Page last updated: 2024-10-22

amitriptyline and Cranial Nerve V Diseases

amitriptyline has been researched along with Cranial Nerve V Diseases in 2 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kasahara, M1
Ichinohe, T1
Sano, T1
Fukuda, K1
Kaneko, Y1
Zadik, Y1
Benoliel, R1
Fleissig, Y1
Casap, N1

Other Studies

2 other studies available for amitriptyline and Cranial Nerve V Diseases

ArticleYear
A case of zoster sine herpete of the trigeminal nerve.
    The Bulletin of Tokyo Dental College, 2011, Volume: 52, Issue:1

    Topics: Amitriptyline; Analgesics, Non-Narcotic; Facial Pain; Female; Humans; Immunoglobulin G; Middle Aged;

2011
Painful trigeminal neuropathy induced by oral bisphosphonate-related osteonecrosis of the jaw: a new etiology for the numb-chin syndrome.
    Quintessence international (Berlin, Germany : 1985), 2012, Volume: 43, Issue:2

    Topics: Aged; Alendronate; Amitriptyline; Analgesics, Non-Narcotic; Bisphosphonate-Associated Osteonecrosis

2012